478 related articles for article (PubMed ID: 30138161)
61. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
Cammarota G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934
[TBL] [Abstract][Full Text] [Related]
62. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis.
Hong AS; Yu WY; Hong JM; Cross CL; Azab M; Ohning G; Jayaraj M
J Gastroenterol Hepatol; 2020 Jun; 35(6):932-940. PubMed ID: 31830335
[TBL] [Abstract][Full Text] [Related]
63. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.
Kelly BJ; Tebas P
Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757
[TBL] [Abstract][Full Text] [Related]
64. Fecal microbiota transplantation in ulcerative colitis.
Blanchaert C; Strubbe B; Peeters H
Acta Gastroenterol Belg; 2019; 82(4):519-528. PubMed ID: 31950808
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578
[TBL] [Abstract][Full Text] [Related]
66. The Route to Palatable Fecal Microbiota Transplantation.
Fadda HM
AAPS PharmSciTech; 2020 Apr; 21(3):114. PubMed ID: 32296975
[TBL] [Abstract][Full Text] [Related]
67. Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges.
Kassam Z; Lee CH; Hunt RH
Clin Lab Med; 2014 Dec; 34(4):787-98. PubMed ID: 25439277
[TBL] [Abstract][Full Text] [Related]
68. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
[TBL] [Abstract][Full Text] [Related]
69. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF
Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862
[TBL] [Abstract][Full Text] [Related]
70. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
71. Fecal microbial transplantation: an update.
Bouri S; Hart A
Curr Opin Clin Nutr Metab Care; 2018 Sep; 21(5):405-410. PubMed ID: 29939968
[TBL] [Abstract][Full Text] [Related]
72. Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
Chen B; Avinashi V; Dobson S
J Infect; 2017 Jun; 74 Suppl 1():S120-S127. PubMed ID: 28646951
[TBL] [Abstract][Full Text] [Related]
73. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.
Costello SP; Conlon MA; Vuaran MS; Roberts-Thomson IC; Andrews JM
Aliment Pharmacol Ther; 2015 Oct; 42(8):1011-8. PubMed ID: 26264455
[TBL] [Abstract][Full Text] [Related]
74. [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
Li N; Tian H; Ma C; Ding C; Ge X; Gu L; Zhang X; Yang B; Hua Y; Zhu Y; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):40-46. PubMed ID: 28105618
[TBL] [Abstract][Full Text] [Related]
75. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.
Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ
Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270
[TBL] [Abstract][Full Text] [Related]
76. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.
Moayyedi P; Yuan Y; Baharith H; Ford AC
Med J Aust; 2017 Aug; 207(4):166-172. PubMed ID: 28814204
[TBL] [Abstract][Full Text] [Related]
77. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Merlo G; Graves N; Brain D; Connelly LB
J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
[TBL] [Abstract][Full Text] [Related]
78. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
[TBL] [Abstract][Full Text] [Related]
79. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
[TBL] [Abstract][Full Text] [Related]
80. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
